The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Storms damage homes in Oklahoma and Kansas. But in Houston, most power is restored
Nation vows to further expand opening
China's Xiaomi releases its first self
Israel hails 'success' after blocking unprecedented attack from Iran
Pentagon vows to keep weapons moving to Ukraine as Kyiv faces a renewed assault by Russia
Shota Imanaga continues strong start to major league career as Cubs top Mariners 4
China's Bluetooth headphone market grows in 2023
Intelligent seedling breeding base enhances spring farming efficiency in Chongqing
Why US Catholics are planning pilgrimages in communities across the nation
Liam Ohgren scores his 1st career goal to lead the Wild past the Sharks 6
The government wants to buy their flood
Wealthy New Yorkers are ditching idyllic Manhattan townhouses for doorman